Evaluation of Survival and Success Rates of Zirzonia Dental Implants

April 2, 2023 updated by: Rambam Health Care Campus
Survival and success rates of Zirconia dental implants compared with Titanium implants (Two-Piece Zirconia implants)

Study Overview

Status

Recruiting

Conditions

Detailed Description

In the last three decades the use of dental implants to support oral rehabilitation has become a common treatment in dentistry and orthopedics.

The implants are made of titanium alloy and have shown high safety and effectiveness.

However, the gray color of the implant may be reflected through the gums and impair aesthetics in the areas of the front of the mouth.

Against this background, in recent years, implant companies have developed zirconia implants, which are white in color.

Studies have shown an aesthetic advantage for zirconia implants and zirconia structures compared to titanium when placed in an aesthetic area in patients with thin gums.

Zirconia implants are resistant to high forces and like titanium implants they undergo osteointegration into the bone, another study in dogs demonstrated an improvement in the soft and hard tissue integration in zirconia implants compared to titanium. In addition to the aesthetic benefit, zirconia implants may have an advantage in a less inflammatory response in the tissues surrounding the implant. In recent years, a number of studies have been published showing detachment of titanium particles from titanium implants which cause an inflammatory response and the absorption of supporting bone around the implant. In addition, several laboratory studies have shown an advantage for zirconia implants in terms of bacterial adsorption to the surface of the implant compared to titanium implants. Studies have been found that show higher pathogenic bacterial adsorption to titanium compared to zirconia.

TavMedical was established in 1975 and mainly specializes in the production, development and marketing of consumable medical products.

In 2011 the company began to develop dental products including implants, parts and utensils.

The company specializes mainly in zirconia dental products. Titanium implants are common and well-known implants and the company focuses its activities on promoting zirconia implants, which constitute a significant differentiation from the titanium implants currently sold in the world.

The purpose of developing zirconia dental implants is to introduce zirconia implants as a preferred alternative to the dental implants currently sold from titanium.

Also, improving the implant treatments currently offered by providing an alternative with high aesthetic results. Patients in the modern age are characterized by a high awareness of their health condition and their demand for treatment with high aesthetic results.

The natural tooth and being a metal-free material adapted to a growing trend all over the world.

Research Hypothesis - Based on the literature, the success rate and survival of zirconia implants is similar to titanium implants and stands at about 95% chance of survival.

Thus differences in the survival and success of titanium implants compared to zirconia are not expected.

Clinical inflammation markers and low-level pro-inflammatory cytokines were found around zirconia implants compared to titanium implants.

Aim of the study - Comparison of survival, success and signs of inflammation of zirconia implants compared to titanium implants.

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Haifa, Israel
        • Recruiting
        • Rambam Health Care Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject must have voluntarily signed the informed consent form.
  • Male or female patient aged ≥18 Years old.
  • Replacing a missing tooth by use of implant supported restoration in implantation sites that do not require extensive augmentation procedure.
  • Good primary implant stability at implant placement (35N and more).
  • Compliance with study schedules and arrival at study visits.

Exclusion Criteria:

  • Pregnant or lactating women.
  • Imbalance diabetes.
  • Head and neck rediation therapy.
  • Active Periodontal disease and caries.
  • Patient in need of tooth extraction and immediat implantation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Zirconia dental implant
Patients treated with zirconia dental implant (Tav-dental) to replace missing tooth
Dental implant installation surgery using zirconia one-piece implant (Tav-dental)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate Tav- implant survival.
Time Frame: 12 months
Implant survival means that implants are still in the mouth. at the time of examination, regardless of the state of the prosthesis or patient satisfaction.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate Tav-Implant probing depth (IPD)
Time Frame: 12 months.
refers to the distance from the gingival margin to pocket base (dental pocket).
12 months.
Evaluate Tav-implant Bleeding on probe (BOP)
Time Frame: 12 months.
presence or absence of bleeding of the dental pocket after probing around the implant.
12 months.
Evaluate Tav-implant Gingival index (GI) changes.
Time Frame: 4 weeks, 12 weeks, 12 months
Gingival index (GI) (Löe and Sillness, 1963): scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding, the score is given by visual examining the gingiva around the implant.
4 weeks, 12 weeks, 12 months
Evaluate Tav-implant Plaque index (PI) changes.
Time Frame: 4 weeks, 12 weeks, 12 months
Plaque index (PI) (Sillness and Löe, 1964): The plaque index assesses the amount of dental plaque visible around the teeth and implants, scoring each site on 0 to 3 scale.
4 weeks, 12 weeks, 12 months
Evaluate Tav-implant Pink Esthetic Score (PES) changes.
Time Frame: 4 weeks, 12 weeks, 12 months.

Pink Esthetic Score (PES) (Fürhauser 2005): evaluates the esthetic outcome of soft tissue around implant-supported single crowns, the score is given by visual examining the gingiva around the implant.

A score of 2, 1, or 0 is assigned to all seven parameters. A score of 0 indicated the worst and a score of 2 indicated the best result for each variable, therefore the highest possible score of 14 denoted perfect peri-implant soft tissues.

4 weeks, 12 weeks, 12 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2020

Primary Completion (Anticipated)

December 1, 2024

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

September 2, 2021

First Submitted That Met QC Criteria

October 25, 2021

First Posted (Actual)

November 3, 2021

Study Record Updates

Last Update Posted (Actual)

April 4, 2023

Last Update Submitted That Met QC Criteria

April 2, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 0382-19 -RMB CTIL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implantation

Clinical Trials on Zirconia dental implant installation surgery

Subscribe